Advent To Sell German Pharmaceutical Group VIATRIS To Meda AB For 750 Million Euros
10/19/2005 5:09:07 PM
Viatris has operations through own affiliates in 14 countries with a strong focus on larger European markets. The company's most important therapeutic area is respiratory. It also has a strong position in the therapeutic area of pain/inflammation, which is a core therapeutic area for Meda.
comments powered by